Posted by Michael Wonder on 12 Jun 2022
Harvard professors continue to push misconceptions to justify drug price controls
10 June 2022 - The biopharmaceutical industry performed wonderfully during the COVID-19 pandemic.
However, despite the millions of lives saved thanks to delivering both vaccines and therapeutics at equitable prices around the globe, this industry continues to get hammered by industry critics in their assault on drug pricing.
